Company Overview
| Stock Name | 金活醫藥集團有限公司 |
|---|---|
| Stock Code | 01110 |
| Company Full Name | 金活醫藥集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國及香港從事品牌進口醫藥及保健產品的分銷，以及制造和銷售電療、物療設備及一般醫療檢查設備。 |
| Listing Date | 2010-11-25 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省深圳市南山區大新路198號馬家龍創新大廈A座8-9樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.kingworld.com.cn |
| Share Registrar | |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 1.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 120,000,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 2.05 |
|---|---|
| First Day Open | HK$ 2.01 |
| First Day Change | 28.13% |
| First Day Volume | 162517000.0 |
| First Day Turnover | 330273000.0 |
Use of Proceeds
| Use of Proceeds | 1、約60%或130.02百萬港元，將用作收購最多三項分銷業務； 2、約20%或43.34百萬港元，將用作通過于深圳建立其自有配備標準GSP資格的配送中心第一階段以提升其向客戶運送貨物的服務； 3、約10%或21.67百萬港元，將用作增加約3,000產品專柜； 4、約10%或21.67百萬港元，將用作本集團的額外一般營運資金。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
国泰君安融资有限公司 CE AGS488
Overall Coordinators (1)
国泰君安证券（香港）有限公司 CE ABY236
Joint Bookrunners (1)
国泰君安证券（香港）有限公司 CE ABY236
Joint Lead Managers (1)
国泰君安证券（香港）有限公司 CE ABY236
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 趙利生 |
|---|---|
| Company Secretary | 陳漢云 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 趙利生及家族成員(65.88%)；Sinopharm Healthcare Fund L.P.(9.99%) |
|---|
